Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease
Clinical trial NCT05327803 · TERMINATED
Trial details
- NCT number
- NCT05327803
- Sponsor
- AN2 Therapeutics, Inc
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-20
- Primary completion
- 2024-12-18
- Enrollment
- 177
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.